HWM
TMDX icon

Hemington Wealth Management’s Transmedics TMDX Stock Holding History

Hemington Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$0 Buy
+2
New +$234 ﹤0.01% 1725

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hemington Wealth Management's TMDX Position: Q3 2025 in Review

Hemington Wealth Management opened a new position in Transmedics (TMDX) in Q3 2025: 2 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1725 among its holdings.

388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

  • Hemington Wealth Management held 2 shares of Transmedics worth $0 as of Q3 2025.
  • Transmedics was a new Hemington Wealth Management position in Q3 2025.
  • Transmedics made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1725 holding.
  • 388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.